Search

Valerie Rodriguez-garcia

Examiner (ID: 32, Phone: (571)270-5865 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1621, 1759, 1626, 1622
Total Applications
1118
Issued Applications
736
Pending Applications
90
Abandoned Applications
322

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9844533 [patent_doc_number] => 08946450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Composition, synthesis, and use of new substituted pyran and pterin compounds' [patent_app_type] => utility [patent_app_number] => 13/735511 [patent_app_country] => US [patent_app_date] => 2013-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 7432 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13735511 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/735511
Composition, synthesis, and use of new substituted pyran and pterin compounds Jan 6, 2013 Issued
Array ( [id] => 10947072 [patent_doc_number] => 20140350093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'METHODS OF TREATING OR PREVENTING INSULIN RESISTANCE AND ASSOCIATED DISEASES AND CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/370140 [patent_app_country] => US [patent_app_date] => 2013-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6402 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370140 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/370140
Methods of treating or preventing insulin resistance and associated diseases and conditions Jan 2, 2013 Issued
Array ( [id] => 8927506 [patent_doc_number] => 20130183266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/724068 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32790 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724068 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/724068
COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS Dec 20, 2012 Abandoned
Array ( [id] => 9793318 [patent_doc_number] => 20150005262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 14/367152 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12338 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367152 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/367152
HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER Dec 19, 2012 Abandoned
Array ( [id] => 9793570 [patent_doc_number] => 20150005514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'PROCESS FOR THE PRODUCTION OF 4-SUBSTITUTED CHROMANES VIA GOLD CATALYSIS' [patent_app_type] => utility [patent_app_number] => 14/365527 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2608 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365527 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/365527
Process for the production of 4-substituted chromanes via gold catalysis Dec 16, 2012 Issued
Array ( [id] => 9813308 [patent_doc_number] => 20150025254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'PRODUCTION METHOD FOR CYCLOPENTANONE DERIVATIVE, INTERMEDIATE COMPOUND, AND PRODUCTION METHOD FOR INTERMEDIATE COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/372884 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7274 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14372884 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/372884
Production method for cyclopentanone derivative, intermediate compound, and production method for intermediate compound Dec 9, 2012 Issued
Array ( [id] => 9762643 [patent_doc_number] => 08846968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Intermediate of lycopene and preparation method of intermediate thereof' [patent_app_type] => utility [patent_app_number] => 13/692694 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7201 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692694 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/692694
Intermediate of lycopene and preparation method of intermediate thereof Dec 2, 2012 Issued
Array ( [id] => 9113179 [patent_doc_number] => 08569351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity' [patent_app_type] => utility [patent_app_number] => 13/692538 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84702 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692538 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/692538
Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity Dec 2, 2012 Issued
Array ( [id] => 9839772 [patent_doc_number] => 20150031854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'Novel Derivatives of Hemin with Antibacterial and Antiviral Activity' [patent_app_type] => utility [patent_app_number] => 14/358998 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9458 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358998 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/358998
Derivatives of hemin with antibacterial and antiviral activity Nov 14, 2012 Issued
Array ( [id] => 10155657 [patent_doc_number] => 09187414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Method to manufacture surface active compounds such as sulfate betaine' [patent_app_type] => utility [patent_app_number] => 14/356525 [patent_app_country] => US [patent_app_date] => 2012-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7165 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356525 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/356525
Method to manufacture surface active compounds such as sulfate betaine Nov 5, 2012 Issued
Array ( [id] => 8822453 [patent_doc_number] => 20130123498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'PROCESS FOR THE PREPARATION OF ETRAVIRINE AND INTERMEDIATES IN THE SYNTHESIS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/655750 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5775 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655750 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/655750
PROCESS FOR THE PREPARATION OF ETRAVIRINE AND INTERMEDIATES IN THE SYNTHESIS THEREOF Oct 18, 2012 Abandoned
Array ( [id] => 8649581 [patent_doc_number] => 20130035310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels' [patent_app_type] => utility [patent_app_number] => 13/633478 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72565 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633478 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/633478
Piperidine and piperazine phenyl sulfonamides as modulators of ion channels Oct 1, 2012 Issued
Array ( [id] => 8768263 [patent_doc_number] => 20130096300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'LONG WAVELENGTH FLUOROGENIC INTRACELLULAR ION INDICATORS THAT ARE WELL RETAINED IN THE CYTOSOL' [patent_app_type] => utility [patent_app_number] => 13/611374 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21657 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13611374 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/611374
LONG WAVELENGTH FLUOROGENIC INTRACELLULAR ION INDICATORS THAT ARE WELL RETAINED IN THE CYTOSOL Sep 11, 2012 Abandoned
Array ( [id] => 8587167 [patent_doc_number] => 20130005988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => '2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/609553 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6397 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13609553 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/609553
2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS Sep 10, 2012 Abandoned
Array ( [id] => 11198326 [patent_doc_number] => 09428529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Process for purification of trivalent phosphorous ligands that can be used for preparation of catalysts' [patent_app_type] => utility [patent_app_number] => 14/345489 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2597 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345489 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/345489
Process for purification of trivalent phosphorous ligands that can be used for preparation of catalysts Sep 6, 2012 Issued
Array ( [id] => 9735776 [patent_doc_number] => 20140271488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Chiral compounds of varying conformational rigidity and methods of synthesis' [patent_app_type] => utility [patent_app_number] => 14/343426 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21507 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343426 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/343426
Chiral oligomeric pentenoate amides as bio-oligomer mimetics Sep 6, 2012 Issued
Array ( [id] => 9113340 [patent_doc_number] => 08569514 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-10-29 [patent_title] => 'Process for the preparation of strontium ranelate' [patent_app_type] => utility [patent_app_number] => 13/603896 [patent_app_country] => US [patent_app_date] => 2012-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1600 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603896 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/603896
Process for the preparation of strontium ranelate Sep 4, 2012 Issued
Array ( [id] => 9656297 [patent_doc_number] => 20140227302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'GAMMA SECRETASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/342953 [patent_app_country] => US [patent_app_date] => 2012-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342953 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342953
Gamma secretase inhibitors Sep 3, 2012 Issued
Array ( [id] => 9813311 [patent_doc_number] => 20150025256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'Purification of 5-Hydroxymethylfurfural (HMF) by Crystallization' [patent_app_type] => utility [patent_app_number] => 14/239321 [patent_app_country] => US [patent_app_date] => 2012-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1491 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239321 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/239321
Purification of 5-Hydroxymethylfurfural (HMF) by Crystallization Aug 16, 2012 Abandoned
Array ( [id] => 9547016 [patent_doc_number] => 20140171664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'FURFURAL PRODUCTION FROM BIOMASS' [patent_app_type] => utility [patent_app_number] => 14/238202 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4209 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238202 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238202
FURFURAL PRODUCTION FROM BIOMASS Aug 9, 2012 Abandoned
Menu